SCHEMBL4687657

SCHEMBL4687657

CCCCOC(=O)NC(C(=O)O)c1ccc(OCCN2CCOCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
MAPK1 P28482 3/20 0.55
HRH3 Q9Y5N1 2/20 0.55
CYP1A2 P05177 1/20 0.55
CHRM2 P08172 1/20 0.55
CHRM1 P11229 1/20 0.55
HTR2A P28223 1/20 0.55
SCN1A P35498 1/20 0.55
HTR2B P41595 1/20 0.55
KCNH2 Q12809 1/20 0.55
SCN2A Q99250 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
SCN3A Q9NY46 1/20 0.55
KMT2A Q03164 4/20 0.54
MEN1 O00255 2/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
LMNA P02545 3/20 0.54
USP2 O75604 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5227540 0.90 KDM4E (0.56) ALDH1A1MAPK1HRH3CYP1A2CHRM2
SCHEMBL5084989 0.90 ITGB3 (0.52) ALDH1A1MAPK1KMT2AMEN1NPC1
SCHEMBL3379566 0.86 ALDH1A1 (0.53) ALDH1A1HRH3KMT2AMEN1NPC1
SCHEMBL3379563 0.86 ALDH1A1 (0.53) ALDH1A1HRH3KMT2AMEN1NPC1
SCHEMBL3379568 0.86 ALDH1A1 (0.53) ALDH1A1HRH3KMT2AMEN1NPC1
SCHEMBL4686341 0.81 SMN1; SMN2 (0.60) MAPK1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL5505866 0.80 SMN1; SMN2 (0.56) MAPK1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL3645386 0.80 SMN1; SMN2 (0.56) MAPK1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL3378524 0.80 SMN1; SMN2 (0.51) ALDH1A1HRH3KMT2AMEN1NPC1
SCHEMBL31737836 0.80 SMN1; SMN2 (0.51) ALDH1A1HRH3KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989186-A1 HYDANTOIN BASED KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2008-11-12 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed